PMGC Holdings Inc. (ELAB) Financial Statements (2025 and earlier)

Company Profile

Business Address 120 NEWPORT CENTER DRIVE
NEWPORT BEACH, CA 92660
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2025
MRQ
12/31/2024
12/31/2023
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,9843,327
Cash and cash equivalent 3,9843,327
Short-term investments  
Receivables536
Inventory, net of allowances, customer advances and progress billings  496
Inventory  496
Prepaid expense867 
Asset, held-for-sale, not part of disposal group 1,193 
Deposits current assets1 
Other undisclosed current assets 1,061
Total current assets:6,0514,919
Noncurrent Assets
Operating lease, right-of-use asset  207
Property, plant and equipment 153
Long-term investments and receivables 139 
Long-term investments 139 
Intangible assets, net (including goodwill)2,802 
Intangible assets, net (excluding goodwill)2,802 
Deposits noncurrent assets  11
Total noncurrent assets:2,942270
TOTAL ASSETS:8,9935,190
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:481669
Other undisclosed accounts payable and accrued liabilities481669
Debt 40 
Derivative instruments and hedges, liabilities  369
Disposal group, including discontinued operation 549 
Other liabilities  77
Other undisclosed current liabilities729182
Total current liabilities:1,7991,297
Noncurrent Liabilities
Liabilities, other than long-term debt  65
Operating lease, liability  65
Other undisclosed noncurrent liabilities 534 
Total noncurrent liabilities: 53465
Total liabilities:2,3341,363
Equity
Equity, attributable to parent6,6603,827
Common stock02
Additional paid in capital19,92910,849
Accumulated other comprehensive income (loss)(0)0
Accumulated deficit(13,270)(7,024)
Other undisclosed equity, attributable to parent  
Total equity:6,6603,827
TOTAL LIABILITIES AND EQUITY:8,9935,190

Income Statement (P&L) ($ in thousands)

3/31/2025
TTM
12/31/2024
12/31/2023
Revenues 1,713
Realized investment losses  
Cost of revenue (1,713)
Other undisclosed gross profit  1,135
Gross profit: 1,135
Operating expenses(3,664) 
Other undisclosed operating loss  
Operating income (loss):(3,664)1,135
Nonoperating income (expense)13(3,766)
Investment income, nonoperating13 
Other nonoperating income  
Interest and debt expense(735)(20)
Loss from continuing operations:(4,386)(2,651)
Loss from discontinued operations(2,229) 
Other undisclosed net loss  
Net loss:(6,615)(2,651)
Other undisclosed net income (loss) attributable to parent369(1,650)
Net loss available to common stockholders, diluted:(6,246)(4,302)

Comprehensive Income ($ in thousands)

3/31/2025
TTM
12/31/2024
12/31/2023
Net loss:(6,615)(2,651)
Other comprehensive income  
Other undisclosed comprehensive income  
Comprehensive loss:(6,615)(2,651)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent369(1,650)
Comprehensive loss, net of tax, attributable to parent:(6,246)(4,301)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: